Ionis Pharmaceuticals, Inc. (IONS)
74.23
-1.45
(-1.92%)
USD |
NASDAQ |
May 15, 16:00
74.24
+0.01
(+0.01%)
After-Hours: 20:00
Ionis Pharmaceuticals Profit Margin (Quarterly) : -37.60% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biogen, Inc. | 13.29% |
| Alnylam Pharmaceuticals, Inc. | 17.65% |
| BioMarin Pharmaceutical, Inc. | 13.55% |
| Mirum Pharmaceuticals, Inc. | -494.2% |
| Catalyst Pharmaceuticals, Inc. | 42.66% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -60.35% |
| Return on Assets | -10.33% |
| Return on Invested Capital | -11.74% |
| Gross Profit Margin (Quarterly) | 95.76% |
| Operating Margin (Quarterly) | -47.72% |
| Return on Net Operating Assets | -84.70% |